Psychological influences on the irritable bowel syndrome

Minerva Medica

Volumn 95, Issue 5, 2004, Pages 443-450

  Lea, R ^a   Whorwell, P J ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Colonic diseases, functional, diagnosis; Colonic diseases, functional, psychology; Colonic diseases, functional, therapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; MIANSERIN; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

BACKACHE; BEHAVIOR THERAPY; COGNITIVE THERAPY; FIBROMYALGIA; GYNECOLOGIC DISEASE; HUMAN; HYPNOSIS; IRRITABLE COLON; LETHARGY; LONG TERM CARE; NAUSEA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSICAL ABUSE; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL DISORDER; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SATIETY; SEXUAL ABUSE; SLEEP DISORDER; SOCIAL PROBLEM; SOCIAL PSYCHOLOGY; URINARY DYSFUNCTION;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR THERAPY; CONTROLLED CLINICAL TRIALS; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; PSYCHOTHERAPY; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 8344233391     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120-37.
2. Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001;19:643-53.
3. Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whithead WE. Rome II: The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment; A multinational Consensus. McLean VA: Degnon and Associates; 2000.
4. Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis 2001;19:212-8.
5. Houghton LA. Sensory dysfunction and the irritable bowel syndrome. Baillieres Best Pract Res Clin Gastroenterol 1999;13:415-27.
6. Bernstein CN, Frankenstein UN, Rawsthorne P, Pitz M, Summers R, McIntyre MC. Cortical mapping of visceral pain in patients with GI disorders using functional magnetic resonance imaging. Am J Gastroenterol 2002;97:319-27.
7. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000;118:842-8.
8. Ringel Y, Drossman DA, Turkington TG, Bradshaw B, Hawk TC, Bangdiwala S et al. Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci 2003;48:1774-81.
9. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52:1703-7.
10. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804.
11. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-7.
12. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002;123:425-32.
13. Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002;97:1780-4.
14. Collins SM, Vallance B, Barbara G, Borgaonkar M. Putative inflammatory and immunological mechanisms in functional bowel disorders. Baillieres Best Pract Res Clin Gastroenterol 1999;13:429-36.
15. Lea R, Whorwell PJ. Infection and irritability. Gut 2002;51:305-6.
16. Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:439-49.
17. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45 Suppl 2:II25-30.
18. Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep 2003;5:343-50.
19. Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. Am J Med 1992;92:26S-30S.
20. Whitehead WE, Crowell MD. Psychologic considerations in the irritable bowel syndrome. Gastroenterol Clin North Am 1991;20:249-67.
21. Drossman DA, McKee DC, Sandier RS, Mitchell CM, Cramer EM, Lowman BC et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
22. Levy RL, Whitehead WE, Von Korff MR, Feld AD. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000;95:451-6.
23. Pinto C, Lele MV, Joglekar AS, Panwar VS, Dhavale HS. Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome. J Assoc Physicians India 2000;48:589-93.
24. Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-33.
25. Hobbis IC, Turpin G, Read NW. A re-examination of the relationship between abuse experience and functional bowel disorders. Scand J Gastroenterol 2002;37:423-30.
26. Elsenbruch S, Thompson JJ, Hamish MJ, Exton MS, Orr WC. Behavioral and physiological sleep characteristics in women with irritable bowel syndrome. Am J Gastroenterol 2002;97:2306-14.
27. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep 2003;26:747-52.
28. Jarrett M, Heitkemper M, Cain KC, Burr RL, Hertig V. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci 2000;45:952-9.
29. Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998;43:256-61.
30. Maxton DG, Morris J, Whorwell PJ. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic" symptomatology. Gut 1991;32:784-6.
31. Prior A, Whorwell PJ. Gynaecological consultation in patients with the irritable bowel syndrome. Gut 1989;30:996-8.
32. Francis CY, Duffy JN, Whorwell PJ, Morris J. High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. Dig Dis Sci 1997;42:404-7.
33. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000;95:974-80.
34. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
35. Hart A, Kamm MA. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 2002;16:2017-28.
36. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
37. Drossman DA. Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol 1996;22:252-4.
38. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002;51:410-3.
39. Clouse RE. Psychotropic medications for the treatment of functional gastrointestinal disorders. Clin Perspect Gastroenterol 1999;2:348-56.
40. Clouse RE, Prakash C, Anderson RJ, Lustman PJ. Antidepressants for functional gastrointestinal symptoms and syndromes: a meta-analysis. Gastroenterology 2001;120 Suppl 1:A642.
41. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65-72.
42. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47.
43. Broekaert D, Gevers A, Janssens J. A double blind randomised placebo controlled crossover trial of Citalopram, a selective 5-hydroxytryptamine reuptake inhibitor, in irritable bowel syndrome. Gastroenterology 2001;120 Suppl 1:3250.
44. Creed FH, Fernandes I, Guthrie E et al. The cost effectiveness of psychotherapy and SSRI antidepressants for severe irritable bowel syndrome. Gastroenterology 2001;120 Suppl 1:A115.
45. Kuiken SD, Burgers P, Tytgat GNJ, Boeckxstaens GEE. Fluoxetine (Prozac) for the treatment of irritable bowel syndrome. A randomised controlled clinical trial. Gastroenterology 2002;122 Suppl 1:A551.
46. Nair D, Prakash C, Lustman PJ et al. Added value of tricyclic antidepressants for functional gastrointestinal symptoms in patients on selective serotonin re-uptake inhibitors (SSRIs). Am J Gastroenterol 2001;96 Suppl:S316.
47. Bennett P, Wilkinson S. A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psychol 1985;24(Pt 3):215-6.
48. Blanchard EB, Schwarz SP, Neff DF, Gerardi MA. Prediction of outcome from the self-regulatory treatment of irritable bowel syndrome. Behav Res Ther 1988;26:187-90.
49. Blanchard EB, Schwarz SP, Suls JM, Gerardi MA, Scharff L, Greene B et al. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behav Res Ther 1992;30:175-89.
50. Greene B, Blanchard EB. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol 1994;62:576-82.
51. Payne A, Blanchard EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol 1995;63:779-86.
52. Van Dulmen AM, Fennis JF, Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom Med 1996;58:508-14.
53. Toner BB, Segal ZV, Emmott S, Myran D, Ali A, DiGasbarro I et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother 1998;48:215-43.
54. Heymann-Monnikes I, Arnold R, Florin I, Herda C, Melfsen S, Monnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000;95:981-94.
55. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003;98:2209-18.
56. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
57. Svedlund J, Sjodin I, Ottosson JO, Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983;2:589-92.
58. Corney RH, Stanton R, Newell R, Clare A, Fairclough P. Behavioural psychotherapy in the treatment of irritable bowel syndrome. J Psychosom Res 1991;35:461-9.
59. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991;100:450-7.
60. Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003;124:303-17.
61. Hislop IG. Effect of very brief psychotherapy on the irritable bowel syndrome. Med J Aust 1980;2:620-3.
62. Shaw G, Srivastava ED, Sadlier M, Swann P, James JY, Rhodes J. Stress management for irritable bowel syndrome: a controlled trial. Digestion 1991;50:36-42.
63. Voirol MW, Hipolito J. [Anthropo-analytical relaxation in irritable bowel syndrome: results 40 months later]. Schweiz Med Wochenschr 1987;117:1117-9.
64. Keefer L, Blanchard EB. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study. Behav Res Ther 2001;39:801-11.
65. Blanchard EB, Greene B, Scharff L, Schwarz-McMorris SP. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback Self Regul 1993;18:125-32.
66. Leahy A, Clayman C, Mason I, Lloyd G, Epstein O. Computerised biofeedback games: a new method for teaching stress management and its use in irritable bowel syndrome. J R Coll Physicians Lond 1998;32:552-6.
67. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4.
68. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28:423-5.
69. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002;97:954-61.
70. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome: the effect of hypnotherapy. Aliment Pharmacol Ther 1996;10:91-5.
71. Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-42.
72. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31:896-8.
73. Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989;1:424-5.
74. Forbes A, MacAuley S, Chiotakakou-Faliakou E. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome? Int J Colorectal Dis 2000;15:328-34.
75. Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998;23:219-32.
76. Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol Suppl 1999;230:49-51.
77. Palsson OS, Turner MJ, Johnson DA, Burnelt CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605-14.
78. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-9.